Download video

Discovering markers of disease progression in patients with MS treated with natalizumab

73 views

VJNeurology

3 years ago

Discovering markers of disease progression in patients with MS treated with natalizumab

Discovering markers of disease progression in patients with MS treated with natalizumab

Discovering markers of disease progression in patients with MS treated with natalizumab
2:08
Discovering markers of disease progression in patients with MS treated with natalizumab
by VJNeurology
Cognitive relapses as markers of disease progression in MS
1:53
Cognitive relapses as markers of disease progression in MS
by VJNeurology
Bench to Bedside: Multiple Sclerosis and Tysabri, Part 1 - Ted Yednock
34:54
Bench to Bedside: Multiple Sclerosis and Tysabri, Part 1 - Ted Yednock
by Science Communication Lab
The future of biomarkers in MS: novel discoveries and defining protocols
2:12
The future of biomarkers in MS: novel discoveries and defining protocols
by VJNeurology
Benefits of SC natalizumab in MS
2:43
Benefits of SC natalizumab in MS
by VJNeurology
Bench to Bedside: Multiple Sclerosis and Tysabri, Part 2 - Ted Yednock
29:26
Bench to Bedside: Multiple Sclerosis and Tysabri, Part 2 - Ted Yednock
by Science Communication Lab
Surrogate Markers for MS
6:12
Surrogate Markers for MS
by NeurologyLive
Uncovering markers of disease progression in Huntington’s disease
2:08
Uncovering markers of disease progression in Huntington’s disease
by VJNeurology
Natalizumab improves mental and social health in a real-world MS cohort
3:53
Natalizumab improves mental and social health in a real-world MS cohort
by VJNeurology
Additional Insights from Natalizumab Treatment in MS
10:21
Additional Insights from Natalizumab Treatment in MS
by Gavin Giovannoni
Doctors have made a new discovery in multiple sclerosis gene markers
1:36
Doctors have made a new discovery in multiple sclerosis gene markers
by WPLG Local 10
Evaluating Natalizumab’s Risk-Benefit Profile in MS
6:27
Evaluating Natalizumab’s Risk-Benefit Profile in MS
by NeurologyLive
Disease-modifying therapy for multiple sclerosis: Nursing Pharmacology
8:30
Disease-modifying therapy for multiple sclerosis: Nursing Pharmacology
by Osmosis from Elsevier
Comparing exit strategies in natalizumab-responders at high risk for PML
7:33
Comparing exit strategies in natalizumab-responders at high risk for PML
by VJNeurology
Multiple Sclerosis Webinar: A Deep Dive into DMTs
44:42
Multiple Sclerosis Webinar: A Deep Dive into DMTs
by TheMSCenter
Updates on natalizumab and anti-CD20 antibodies for MS
2:21
Updates on natalizumab and anti-CD20 antibodies for MS
by VJNeurology
Tysabri: A Game-Changer in Multiple Sclerosis Treatment - What You Need to Know
9:35
Tysabri: A Game-Changer in Multiple Sclerosis Treatment - What You Need to Know
by Inevid
How Tysabri (natalizumab) Works in Relapsing Multiple Sclerosis
16:01
How Tysabri (natalizumab) Works in Relapsing Multiple Sclerosis
by MedInfo